XYNOMIC PHARMACEUTICALS HOLDINGS, INC.

Xynomic Pharmaceuticals Holdings, Inc. is a clinical-stage biopharmaceutical company whose SEC registration bears CIK 0001697805; no exchange ticker is recorded in this filing. The company operates in the healthcare and life sciences sector, focused on oncology drug development. Its Form 10-Q, filed with the SEC on August 15, 2019 under accession number 0001213900-19-016052, reflects reporting obligations consistent with a SPAC de-SPAC transition into an operating entity during that period. The filing provides a quarterly financial snapshot for investors and analysts tracking the company's post-combination progress. Sign up for a SpacDesk account to access the full data profile, filing history, and deal timeline for Xynomic Pharmaceuticals Holdings and hundreds of other SPAC transactions.